Cochlear Ltd:附录4E 08/15 05:30· 业绩公告 Cochlear对高管团队进行调整;股价上涨4% Cochlear(ASX:COH)根据周五在澳大利亚证券交易所的文件透露,对其高管团队进行了多次调整。Richard Brook将辞去欧洲、中东和 MT Newswires07/26 10:35 麦格理将Cochlear的目标价上调18%至每股A$300.00。>COH.AU 麦格理将科利尔的目...
Cochlear Ltd:附录4E 08/15 05:30· 业绩公告 Cochlear对高管团队进行调整;股价上涨4% Cochlear(ASX:COH)根据周五在澳大利亚证券交易所的文件透露,对其高管团队进行了多次调整。Richard Brook将辞去欧洲、中东和 MT Newswires07/26 10:35 麦格理将Cochlear的目标价上调18%至每股A$300.00。>COH.AU 麦格理将科利尔的目...
On Friday, Cochlear Ltd (CHEOF:PKC) closed at 200.84, -15.39% below its 52-week high of 237.38, set on Jul 31, 2024. 52-week range Today 149.04Oct 27 2023237.38Jul 31 2024 Short selling activity Low Med HighProvided by S&P Global Market Intelligence Open 200.84 High 200.84 Low 200.84 ...
As of last trade Cochlear Ltd (OC50:MUN) traded at 89.50, -13.11% below its 52-week high of 103.00, set on Aug 02, 2024. 52-week range Today 74.00Nov 14 2023103.00Aug 02 2024 Short selling activity Low Med HighProvided by S&P Global Market Intelligence Open 89.50 High 89.50 Low 89.50...
ANGEL ROBOTICS CO., LTD. -1.38%-9.93%--277M DELCATH SYSTEMS, INC. +7.57%+25.06%+167.10%+8.71%266M Average+0.41%-1.65%+31.16%-22.13%7.38B Weighted average by Cap.-0.10%-1.29%+20.22%-11.77% See all sector performances Financials
GURUFOCUS.COMSTOCK LISTUSAOTCPKCochlear Ltd (OTCPK:CHEOY) NAICS : 339113 ISIN : US1914592050 https://www.cochlear.com 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109 Share Class Description: CHEOY: ADR Compare Compare ASX:PNV ...
ACB News《澳华财经在线》2月8日讯,澳洲人工耳蜗制造商Cochlear(ASX:COH)周四发布公告称,在截至去年12月31日的半年内,人工耳蜗销售收入增长好于预期,因此决定上调盈利指引。预计2024财年基本净利润将达到3.85亿至4亿澳元,比2023财年增长26%至31%,比去年8月提出的3.55亿至3.75亿澳元的中期指引跃升8%。本财年上半...
By Shanghai Yongming Electronic Co.,Ltd 10.31.2024 A Blueprint for a Connected Future in Semiconductor and Electronics By Ted Pawela, Chief Customer Officer, Altium 10.30.2024 Briocean at electronica 2024: The Perfect Blend of Networking and Activities! By Briocean 10.29.2024 Improving the Heari...
Cochlear Ltd. and Sensorion SA have published encouraging results on the combination of a molecule with a cochlear implant. Their proof-of-concept phase 2a study involved the combination of an orphan drug recognized in both Europe and the U.S. with cutting edge hearing aid implants to enhance ...
Recent company updates:Seelatest news, announcements and system status messagesfrom Cochlear. Smaller, smarter, better connected. The Nucleus 8 Sound Processor opens up a world of possibilities. Learn more Help me find... Please select The Cochlear™ Nucleus® System - Small. Smart. Simple. ...